Exergen Corporation: New Data Confirms No-Touch Thermometers Miss Five Out of Six Fevers

▴ Exergen Corporation: New Data Confirms No-Touch Thermometers Miss Five Out of Six Fevers
Non-contact thermometers are proven to be ineffective in measuring actual body temperature, while the accuracy of the TemporalScanner is supported by more than 80 peer-reviewed published clinical studies.

As COVID-19 continues to set new records nationwide, the importance of understanding the difference in accuracy between temporal artery thermometers (TAT) and non-contact devices – now used widely for public temperature screenings – is of paramount importance. Non-contact thermometers are proven to be ineffective in measuring actual body temperature, while the accuracy of the TemporalScanner is supported by more than 80 peer-reviewed published clinical studies. This has serious ramifications for family health and public safety.  

A new study in the American Journal of Infection Control is the first to compare the accuracy of no-touch thermometers to temporal artery thermometers. Australian researchers conducted a prospective observational study on a sample of 265 non-infectious patients at two hospitals.

When body temperatures read below 99.5 degrees Fahrenheit, the thermometers showed similar results, but as temperatures rose above that, non-contact scanners’ accuracy decreased. Temperatures were farther apart as they rose. The non-contact scanners missed five out of every six fevers detected by Exergen temporal artery thermometers.

According to the authors, “This is the first study to compare the accuracy of non-contact infrared thermometers (NCIT) to TAT in adult patients. Although mass fever screening is currently underway using NCIT, these results indicate that the NCIT may not be the most accurate device for fever mass screening during a pandemic.”

“During this escalating and unpredictable pandemic, there is one constant in helping to ensure public safety: the ability to accurately screen for fever,” said Francesco Pompei, Ph.D., CEO of Exergen Corporation. “Non-contact thermometers are proven to be inaccurate in measuring core body temperature, yet they’ve been used extensively from the start of the pandemic, giving a false sense of security. In public settings, they are large ‘theater,” and as such their use should be seriously questioned. Only thermometers with extensive clinical studies, such as the Exergen TemporalScanner, can be trusted for accuracy during these threatening times of COVID.”

ABOUT EXERGEN CORPORATION
Exergen manufactures and markets two series of the TemporalScanner thermometer: a professional version for hospitals and clinics, and a consumer version sold in major retailers nationwide. More than two billion temperatures are taken each year with TemporalScanners. Used in thousands of hospitals and clinics across the country as well as in millions of homes, TemporalScanners are the 1 preference of pediatricians, 1 preference of nurses, and 1 selling retail thermometer. The Exergen TemporalScanner's accuracy is supported by more than 80 peer-reviewed published clinical studies covering all ages from preterm infants to geriatrics and all care areas from hospitals to homes. 

Tags : #ExergenCorporation #Non-contactthermometers #thermometers #Covid19Infection #InfectionControl #publicsafety

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024
On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology NursesMay 14, 2024
Shiprocket announces Shiprocket Growth Academy to upskill 100,000 Indian MSMEs through eCommerce learningMay 14, 2024